Evidence map›Paper›PMID 31604821›Full record

ArticleThe Journal of biological chemistry2019

Differential regulation of AMP-activated protein kinase in healthy and cancer cells explains why V-ATPase inhibition selectively kills cancer cells.

Karin Bartel, Rolf Müller, Karin von Schwarzenberg

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.5field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Recent progress in small molecules targeting the acidic tumor microenvironment.Journal of enzyme inhibition and medicinal chemistry · 2026
    Review
  2. Review
  3. Review
  4. V-ATPase in cancer: mechanistic insights and therapeutic potentials.Cell communication and signaling : CCS · 2024
    Review
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Karin BartelDepartment of Pharmacy, Pharmaceutical Biology, Ludwig Maximilians University, 81377 Munich, Germany.
Rolf MüllerHelmholtz Center for Pharmaceutical Research Saarland, Helmholtz Centre for Infection Research, and Department of Pharmacy at Saarland University, Saarland University Campus, 66123 Saarbrücken, Germany.
Karin von SchwarzenbergDepartment of Pharmacy, Pharmaceutical Biology, Ludwig Maximilians University, 81377 Munich, Germany karin.von.schwarzenberg@cup.uni-muenchen.de.
Ludwig-Maximilians-Universität München · DESaarland University · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The cellular energy sensor AMP-activated protein kinase (AMPK) is a metabolic hub regulating various pathways involved in tumor metabolism. Here we report that vacuolar H

Indexed as

AMP-Activated Protein KinasesApoptosisCell LineCell Line, TumorEnzyme ActivationEnzyme InhibitorsHumansMacrolidesNeoplasmsPhosphorylationReactive Oxygen SpeciesThiazolesVacuolar Proton-Translocating ATPasesAMP-Activated Protein Kinasesarchazolid AEnzyme InhibitorsMacrolidesReactive Oxygen SpeciesThiazolesVacuolar Proton-Translocating ATPasesAMP-activated kinase (AMPK)apoptosisarchazolidcancerglucose starvationmetabolismpH homeostasisreactive oxygen species (ROS)tumor suppressorvacuolar ATPase

Identifiers

PMID31604821
PMCPMC6873172
OpenAlexW2979485461

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.